Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - OPERATING INCOME
Operating Income APLS - Apellis Pharmaceuticals, Inc.
-517 M
LAST VALUE
1.80%
2 YEAR CAGR
-32.23%
5 YEAR CAGR
-62.49%
10 YEAR CAGR